March 26, 2019
Our Therigy team just returned from the AMCP Managed Care and Specialty Pharmacy 2019 Annual Meeting in San Diego, CA, where a poster was presented on the recent completion of a quality initiative: "Improving Quality of Care in Rheumatoid Arthritis (RA) Utilizing Hospital-Based Specialty Pharmacies in Monitoring Disease Activity.” The poster presentation highlighted the capabilities of hospital-based specialty pharmacists and software to deliver interventions and document patient-reported disease activity to collaborate with rheumatologists and enhance treatment management.
“We are very proud to announce the results of this peer-reviewed, patient-reported outcomes initiative conducted in collaboration with five leading hospital-based specialty pharmacies,” states, Lily Duong, PharmD, RPh, Chief Clinical Officer, Therigy. “For the first time, multiple health system specialty pharmacies, executing the same protocol via enabling software, have demonstrated the capacity to affect patient engagement, collect validated patient-reported outcomes and collaborate with rheumatologists to support enhanced compliance with American College of Rheumatology care guidelines.”
The Quality Initiative concludes that software supporting pharmacy engagement with rheumatologists is an emerging opportunity in optimizing treatment management for RA patients.
Download a copy of the abstract entitled “Improving Quality of Care in Rheumatoid Arthritis (RA) Utilizing Hospital-Based Specialty Pharmacies in Monitoring Disease Activity,” by filling out the popup form below. ( here.)
You may also find a copy of the abstract published in the Journal of Managed Care Pharmacy, page 88, here.
If you are interested in more information on outcomes or quality initiatives, learn more here.